Skip to search formSkip to main contentSkip to account menu

isoniazid

Known as: Pyridine-4-carboxylic acid hydrazide, INH, Isonicotinic Acid Hydrazide 
A synthetic derivative of nicotinic acid with anti-mycobacterial properties. Although its mechanism of action is still unclear, isoniazid appears to… 
National Institutes of Health

Related topics

Related topics

44 relations

Narrower (22)

1-isonicotinyl-2-lactosylhydrazine1-isonicotinyl-2-nonanoyl hydrazineBT 103DBDY-(Gly-INH)2
4-pyridinecarbohydrazideDrug toxicityIn BloodIsoniazid:ACnc:Pt:Ser/Plas:Qn

Broader (6)

Antitubercular AgentsEthersFatty Acid Synthesis InhibitorsHydrazine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
BACKGROUND In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)-associated tuberculosis is high. We conducted… 
Highly Cited
2011
Highly Cited
2011
Three months of rifapentine and isoniazid for latent tuberculosis infection.
BACKGROUND Treatment of latent Mycobacterium tuberculosis infection is an essential component of tuberculosis control and… 
Highly Cited
2002
Highly Cited
2002
The diagnosis and management of
Highly Cited
1998
Highly Cited
1998
Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
The preferred antitubercular drug isoniazid specifically targets a long-chain enoyl-acyl carrier protein reductase (InhA), an… 
Highly Cited
1994
Highly Cited
1994
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Isoniazid (isonicotinic acid hydrazide, INH) is one of the most widely used antituberculosis drugs, yet its precise target of… 
Highly Cited
1992
Highly Cited
1992
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
TUBERCULOSIS is responsible for one in four of all avoidable adult deaths in developing countries1. Increased frequency and… 
Highly Cited
1990
Highly Cited
1990
Diagnosis and treatment of disease caused by nontuberculous mycobacteria.
Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease For patients with a cavitary infiltrate: Two or more sputums or… 
Review
1976
Review
1976
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
The clinical spectrum of isoniazid-induced liver injury seems to be clinically, biochemically, and histologically… 
Highly Cited
1974
Highly Cited
1974
The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.
With a stepwise degradation and terminal labeling procedure the 3'-terminal sequence of E. coli 16S ribosomal RNA is shown to be… 
Highly Cited
1960
Highly Cited
1960
Genetic Control of Isoniazid Metabolism in Man
collars limits their use to some extent" (Lancet, 1958). It has also been suggested that conservative treatment should not… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)